Micrometastases in thyroid cancer. An important finding?

Surgical Oncology

Volumn 17, Issue 3, 2008, Pages 253-258

  Cranshaw, Isaac M ^a   Carnaille, Bruno ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Metastases; Micrometastases; Prognosis; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE;

CANCER CONTROL; CANCER INCIDENCE; CANCER SIZE; DISEASE CONTROL; DISEASE COURSE; DISSECTION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MICROMETASTASIS; NECK DISSECTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL APPROACH; THYROID CANCER; THYROIDECTOMY;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; THYROID NEOPLASMS;

EID: 50249119597     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2008.04.005     Document Type: Review

References (42)

1. DeGroot L.J., Kaplan E.L., McCormick M., and Straus F.H. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71 (1990) 414-424
2. Harwood J., Clark O.H., and Dunphy J.E. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 136 (1978) 107-112
3. McConahey W.M., Hay I.D., Woolner L.B., van Heerden J.A., and Taylor W.F. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 61 (1986) 978-996
4. Mazzeferri E.L., and Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97 (1994) 418-428
5. Byar D.P., Green S.B., Dor P., Williams E.D., Colon J., van Gilse H.A., et al. A prognostic index for thyroid carcinoma: a study of the E.O.R.T.C. thyroid cancer cooperative group. Eur J Cancer 15 (1979) 1033-1041
6. Hay I.D., Grant C.S., Taylor W.F., and McConahey W.M. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102 (1987) 1088-1095
7. Hay I.D., Bergstralh E.J., Goellner J.R., Ebersold J.R., and Grant C.S. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114 (1993) 1050-1058
8. Cady B., and Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104 (1988) 947-953
9. Kukkonen S.T., Haapiainen R.K., Rranssila K.O., and Sivula A.H. Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg 14 (1990) 837-842
10. Mazzaferri E.L., and Young R.L. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70 (1981) 511-518
11. McHenry C.R., Rosen I.B., and Walfish P.G. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 162 (1991) 353-356
12. Scheumann G.F., Gimm O., Wegener G., Hundeshagen H., and Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18 4 (1994) 559-568
13. Ohshima A., Yamashita H., Noguchi S., Uchino S., Watanabe S., Toda M., et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 135 10 (2000) 1194-1199
14. Yamashita H., Noguchi S., Murakami N., Kawamoto H., and Watanabe S. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80 12 (1997) 2268-2272
15. Palazzo F.F., Gosnell J., Savio R., Reeve T., Sidhu S., Sywak M., et al. Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur J Surg Oncol 32 3 (2006) 340-344
16. Kourvaraki M.A., Lee J., Shapiro S.E., Sherman S.I., and Evans D.B. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136 6 (2004) 1183-1191
17. Roher H.D., Simon D., and Goretzki P.E. Guidelines in oncologic surgery - malignant thyroid tumours. Lang Arch Chir Kongressbd 114 (1997) 142-145
18. Cooper D.S., Doherty G., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 2 (2006) 1-33
19. Wiseman S.M., Hicks Jr. W.L., Chu Q.D., and Rigual N.R. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 11 3 (2002) 137-142
20. Attie J.N. Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer Clin Oncol 24 (1988) 315-324
21. Noguchi M., Tanaka S., and Sakata N. Subtotal thyroidectomy and modified radical neck dissection for thyroid cancer. Surgery 6 (1982) 603-607
22. Noguchi M., Earashi M., Kitagawa H., Ohta N., Thomas M., Miyazaki I., et al. Papillary thyroid cancer and its surgical management. J Surg Oncol 49 (1992) 140-149
23. Noguchi S., Murakami N., Yamashita H., Toda M., and Kawamoto H. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 133 (1998) 276-281
24. Huvos A.G., Hutter R.V., and Berg J.W. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173 1 (1971) 44-46
25. Seigel R.J. Surgical pathology of lymph nodes in cancer staging: routine and specialized techniques. Surg Oncol Clin Nth Am 5 1 (1996) 25-31
26. Machens A., Hinze R., Thomusch O., and Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26 (2002) 22-28
27. Noguchi S., Noguchi A., and Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26 (1970) 1053-1060
28. Qubain S.W., Nakano S., Baba M., Takao S., and Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131 3 (2002) 249-256
29. Mirallie E., Visset J., Sagan C., Hamy A., Le Bodic M.F., and Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 23 (1999) 970-974
30. Gimm O., Rath F.W., and Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 85 2 (1998) 252-254
31. Machens A., Holzhausen H.J., and Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 139 1 (2004) 43-45
32. Fukui Y., Yamakawa T., Taniki T., Numoto S., Miki H., and Monden Y. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 92 11 (2001) 2868-2874
33. Dixon E., McKinnon J., and Pasieka J.L. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 24 11 (2000) 1396-1401
34. Carcoforo P., Feggi L., Trasforini G., Lanzara S., Sortini D., Zulian V., et al. Use of preoperative lymphoscintigraphy and intraoperative gamma-probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma. Eur J Surg Oncol 33 9 (2007) 1075-1080
35. Cranshaw I.M., Jany T., Arnalsteen L., Pattou F., and Carnaille B. Significance of lymph node micrometastases in papillary thyroid carcinoma. ANZ J Surg 77 Suppl. 1 (2007) A21
36. Shaha A.R., Shah J., and Loree T.R. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups. Head Neck 20 1 (1998) 26-30
37. Grebe S.K., and Hay I.D. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5 1 (1996) 43-63
38. Tubiana M., Perez R., Parmentier C., and Monnier J.P. The survival of patients with thyroid cancers treated with radioactive iodine. Apropos of 147 cases followed up for more than 5 years. Presse Med 76 (1968) 1999-2002
39. Hay I.D., Thompson G.B., Grant C.S., Bergstralh E.J., Dvorak C.E., Gorman C.A., et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26 (2002) 879-885
40. Sawka A.M., Thephamongkhol K., Brouwers M., Thabane L., Browman G., and Gerstein H.C. Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89 (2004) 3668-3676
41. Hay I.D., McConahey W.M., and Goellner J.R. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 113 (2002) 241-260
42. Ito Y., Uruno T., Nakano K., Takamura Y., Miya A., Kobayashi K., et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13 4 (2003) 381-387